The latest announcement is out from Keros Therapeutics (KROS).
Simon Cooper, the Chief Medical Officer of Keros Therapeutics, has voluntarily resigned to seek other opportunities, effective March 12, 2024. His departure is amicable, with no disagreements reported. The company is actively searching for a replacement and extends gratitude to Cooper for his valuable contributions to the team.
For detailed information about KROS stock, go to TipRanks’ Stock Analysis page.
